nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Cytochrome P450 2D6 Inhibitors—Clobazam—epilepsy syndrome	0.562	1	CiPCiCtD
Desvenlafaxine—SLC6A4—epilepsy syndrome	0.149	1	CbGaD
Desvenlafaxine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0134	0.0879	CbGbCtD
Desvenlafaxine—CYP3A4—Trimethadione—epilepsy syndrome	0.0125	0.0817	CbGbCtD
Desvenlafaxine—CYP3A4—Felbamate—epilepsy syndrome	0.0125	0.0817	CbGbCtD
Desvenlafaxine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0117	0.0768	CbGbCtD
Desvenlafaxine—CYP3A4—Clonazepam—epilepsy syndrome	0.0106	0.0694	CbGbCtD
Desvenlafaxine—CYP3A4—Clobazam—epilepsy syndrome	0.0102	0.0666	CbGbCtD
Desvenlafaxine—CYP3A4—Rufinamide—epilepsy syndrome	0.00863	0.0566	CbGbCtD
Desvenlafaxine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00841	0.0552	CbGbCtD
Desvenlafaxine—CYP3A4—Primidone—epilepsy syndrome	0.00785	0.0515	CbGbCtD
Desvenlafaxine—CYP3A4—Phenytoin—epilepsy syndrome	0.00755	0.0495	CbGbCtD
Desvenlafaxine—CYP3A4—Propofol—epilepsy syndrome	0.00704	0.0462	CbGbCtD
Desvenlafaxine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00673	0.0441	CbGbCtD
Desvenlafaxine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00673	0.0441	CbGbCtD
Desvenlafaxine—CYP3A4—Midazolam—epilepsy syndrome	0.00663	0.0435	CbGbCtD
Desvenlafaxine—CYP3A4—Diazepam—epilepsy syndrome	0.00638	0.0418	CbGbCtD
Desvenlafaxine—CYP3A4—Zonisamide—epilepsy syndrome	0.00622	0.0408	CbGbCtD
Desvenlafaxine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00503	0.033	CbGbCtD
Desvenlafaxine—CYP3A4—Topiramate—epilepsy syndrome	0.00453	0.0297	CbGbCtD
Desvenlafaxine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00373	0.245	CbGeAlD
Desvenlafaxine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00198	0.13	CbGeAlD
Desvenlafaxine—SLC6A4—ganglion—epilepsy syndrome	0.00125	0.082	CbGeAlD
Desvenlafaxine—SLC6A2—ganglion—epilepsy syndrome	0.0011	0.0722	CbGeAlD
Desvenlafaxine—SLC6A4—hindbrain—epilepsy syndrome	0.000949	0.0622	CbGeAlD
Desvenlafaxine—SLC6A4—brainstem—epilepsy syndrome	0.000544	0.0357	CbGeAlD
Desvenlafaxine—SLC6A4—forebrain—epilepsy syndrome	0.000525	0.0344	CbGeAlD
Desvenlafaxine—SLC6A4—telencephalon—epilepsy syndrome	0.000483	0.0316	CbGeAlD
Desvenlafaxine—SLC6A2—brainstem—epilepsy syndrome	0.000479	0.0314	CbGeAlD
Desvenlafaxine—SLC6A2—forebrain—epilepsy syndrome	0.000462	0.0303	CbGeAlD
Desvenlafaxine—SLC6A4—Monoamine Transport—SYN1—epilepsy syndrome	0.000459	0.025	CbGpPWpGaD
Desvenlafaxine—Cyclopentolate—CHRM3—epilepsy syndrome	0.000455	0.205	CrCbGaD
Desvenlafaxine—SLC6A2—telencephalon—epilepsy syndrome	0.000425	0.0279	CbGeAlD
Desvenlafaxine—Cyclopentolate—CHRM1—epilepsy syndrome	0.000424	0.191	CrCbGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—SYN1—epilepsy syndrome	0.000394	0.0215	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—epilepsy syndrome	0.000366	0.0199	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—STX1B—epilepsy syndrome	0.000361	0.0197	CbGpPWpGaD
Desvenlafaxine—SLC6A4—midbrain—epilepsy syndrome	0.000347	0.0227	CbGeAlD
Desvenlafaxine—SLC6A4—spinal cord—epilepsy syndrome	0.000338	0.0222	CbGeAlD
Desvenlafaxine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000334	0.0219	CbGeAlD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SYN1—epilepsy syndrome	0.000316	0.0172	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—NSF—epilepsy syndrome	0.000316	0.0172	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—STXBP1—epilepsy syndrome	0.000307	0.0168	CbGpPWpGaD
Desvenlafaxine—SLC6A4—head—epilepsy syndrome	0.000301	0.0197	CbGeAlD
Desvenlafaxine—Venlafaxine—ABCG2—epilepsy syndrome	0.000291	0.131	CrCbGaD
Desvenlafaxine—Cyclopentolate—BCHE—epilepsy syndrome	0.000289	0.13	CrCbGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—CACNA1A—epilepsy syndrome	0.000286	0.0156	CbGpPWpGaD
Desvenlafaxine—SLC6A4—nervous system—epilepsy syndrome	0.000285	0.0187	CbGeAlD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.000281	0.0153	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—SLC6A1—epilepsy syndrome	0.00028	0.0153	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—HRH3—epilepsy syndrome	0.000276	0.015	CbGpPWpGaD
Desvenlafaxine—SLC6A4—central nervous system—epilepsy syndrome	0.000275	0.018	CbGeAlD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SLC17A7—epilepsy syndrome	0.000274	0.0149	CbGpPWpGaD
Desvenlafaxine—SLC6A2—head—epilepsy syndrome	0.000265	0.0173	CbGeAlD
Desvenlafaxine—SLC6A2—Amine compound SLC transporters—SLC6A1—epilepsy syndrome	0.000254	0.0138	CbGpPWpGaD
Desvenlafaxine—SLC6A2—nervous system—epilepsy syndrome	0.000251	0.0164	CbGeAlD
Desvenlafaxine—SLC6A2—central nervous system—epilepsy syndrome	0.000242	0.0158	CbGeAlD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A1—epilepsy syndrome	0.000241	0.0131	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—SLC6A4—epilepsy syndrome	0.000241	0.109	CrCbGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—HRH3—epilepsy syndrome	0.000237	0.0129	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—CYP2C19—epilepsy syndrome	0.000228	0.103	CrCbGaD
Desvenlafaxine—SLC6A4—brain—epilepsy syndrome	0.000218	0.0143	CbGeAlD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SLC1A3—epilepsy syndrome	0.000217	0.0118	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000213	0.0116	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—NOS1—epilepsy syndrome	0.0002	0.0109	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TH—epilepsy syndrome	0.0002	0.0109	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A4—epilepsy syndrome	0.000193	0.0105	CbGpPWpGaD
Desvenlafaxine—SLC6A2—brain—epilepsy syndrome	0.000192	0.0126	CbGeAlD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—epilepsy syndrome	0.000191	0.0104	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIX3—epilepsy syndrome	0.000174	0.00949	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PROX1—epilepsy syndrome	0.000174	0.00949	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—KCND2—epilepsy syndrome	0.000174	0.00949	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TH—epilepsy syndrome	0.000172	0.00936	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—NOS1—epilepsy syndrome	0.000172	0.00936	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00017	0.00929	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—CYP2D6—epilepsy syndrome	0.000169	0.0764	CrCbGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000162	0.00881	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000162	0.00881	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000158	0.00864	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A8—epilepsy syndrome	0.000147	0.00799	CbGpPWpGaD
Desvenlafaxine—CYP3A4—nervous system—epilepsy syndrome	0.00014	0.00915	CbGeAlD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000136	0.00743	CbGpPWpGaD
Desvenlafaxine—CYP3A4—central nervous system—epilepsy syndrome	0.000134	0.00881	CbGeAlD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000132	0.0072	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TSC2—epilepsy syndrome	0.000131	0.00712	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—AGT—epilepsy syndrome	0.00013	0.00711	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000126	0.00685	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000122	0.00667	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000122	0.00664	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000122	0.00664	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000122	0.00664	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—ABCB1—epilepsy syndrome	0.000121	0.0545	CrCbGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000117	0.00636	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000116	0.00631	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000113	0.00617	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TSC2—epilepsy syndrome	0.000112	0.00612	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NTRK3—epilepsy syndrome	0.000112	0.00611	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—AGT—epilepsy syndrome	0.000112	0.00611	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000112	0.0061	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000112	0.0061	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000111	0.00607	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000108	0.00588	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000106	0.0058	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000104	0.00568	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	9.92e-05	0.00541	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	9.6e-05	0.00523	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	9.23e-05	0.00503	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	9.23e-05	0.00503	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	9.23e-05	0.00503	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NPY2R—epilepsy syndrome	9.14e-05	0.00498	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TXNRD1—epilepsy syndrome	9.14e-05	0.00498	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	9.1e-05	0.00496	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—ABCC2—epilepsy syndrome	8.95e-05	0.00488	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	8.85e-05	0.00483	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	8.85e-05	0.00483	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	8.81e-05	0.0048	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	8.49e-05	0.00463	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	8.32e-05	0.00454	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC6A1—epilepsy syndrome	8.32e-05	0.00454	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	8.16e-05	0.00445	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—epilepsy syndrome	8.15e-05	0.00444	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—UBE3A—epilepsy syndrome	8.11e-05	0.00442	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CHRM1—epilepsy syndrome	7.78e-05	0.00424	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—ABCC2—epilepsy syndrome	7.7e-05	0.00419	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	7.61e-05	0.00415	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—KCNMA1—epilepsy syndrome	7.58e-05	0.00413	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	7.47e-05	0.00407	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	7.32e-05	0.00399	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	7.18e-05	0.00391	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A1—epilepsy syndrome	7.16e-05	0.0039	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	7.03e-05	0.00383	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—epilepsy syndrome	7e-05	0.00382	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	7e-05	0.00381	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	7e-05	0.00381	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	6.95e-05	0.00379	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	6.95e-05	0.00379	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUND—epilepsy syndrome	6.8e-05	0.0037	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	6.79e-05	0.0037	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	6.7e-05	0.00365	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK10—epilepsy syndrome	6.5e-05	0.00354	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	6.4e-05	0.00349	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	6.19e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	6.19e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	6.19e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	6.19e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	6.18e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	6.16e-05	0.00336	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	6.14e-05	0.00334	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SST—epilepsy syndrome	6.14e-05	0.00334	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	6.11e-05	0.00333	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CHRNB2—epilepsy syndrome	6.1e-05	0.00333	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC2A1—epilepsy syndrome	6.02e-05	0.00328	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	5.95e-05	0.00324	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—epilepsy syndrome	5.91e-05	0.00322	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	5.83e-05	0.00318	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A4—epilepsy syndrome	5.72e-05	0.00312	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.66e-05	0.00309	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HBEGF—epilepsy syndrome	5.66e-05	0.00308	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TH—epilepsy syndrome	5.62e-05	0.00306	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CRH—epilepsy syndrome	5.54e-05	0.00302	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.24e-05	0.00286	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC2A1—epilepsy syndrome	5.17e-05	0.00282	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—epilepsy syndrome	5.08e-05	0.00277	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	5.06e-05	0.00276	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	4.95e-05	0.0027	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—epilepsy syndrome	4.95e-05	0.0027	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HBEGF—epilepsy syndrome	4.86e-05	0.00265	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.69e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.69e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.69e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	4.65e-05	0.00253	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TH—epilepsy syndrome	4.59e-05	0.0025	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	4.58e-05	0.0025	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	4.54e-05	0.00247	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HTR7—epilepsy syndrome	4.51e-05	0.00246	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	4.51e-05	0.00246	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.48e-05	0.00244	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.48e-05	0.00244	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	4.4e-05	0.0024	CbGpPWpGaD
Desvenlafaxine—Nausea—Acetazolamide—epilepsy syndrome	4.38e-05	0.000436	CcSEcCtD
Desvenlafaxine—Dizziness—Levetiracetam—epilepsy syndrome	4.38e-05	0.000435	CcSEcCtD
Desvenlafaxine—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.37e-05	0.000435	CcSEcCtD
Desvenlafaxine—Vomiting—Propofol—epilepsy syndrome	4.36e-05	0.000433	CcSEcCtD
Desvenlafaxine—Rash—Propofol—epilepsy syndrome	4.32e-05	0.000429	CcSEcCtD
Desvenlafaxine—Dermatitis—Propofol—epilepsy syndrome	4.32e-05	0.000429	CcSEcCtD
Desvenlafaxine—Hypertension—Valproic Acid—epilepsy syndrome	4.31e-05	0.000429	CcSEcCtD
Desvenlafaxine—Immune system disorder—Gabapentin—epilepsy syndrome	4.3e-05	0.000427	CcSEcCtD
Desvenlafaxine—Headache—Propofol—epilepsy syndrome	4.29e-05	0.000427	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Gabapentin—epilepsy syndrome	4.29e-05	0.000426	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Zonisamide—epilepsy syndrome	4.28e-05	0.000425	CcSEcCtD
Desvenlafaxine—Chills—Gabapentin—epilepsy syndrome	4.27e-05	0.000424	CcSEcCtD
Desvenlafaxine—Vomiting—Midazolam—epilepsy syndrome	4.26e-05	0.000424	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vigabatrin—epilepsy syndrome	4.26e-05	0.000424	CcSEcCtD
Desvenlafaxine—Asthenia—Felbamate—epilepsy syndrome	4.26e-05	0.000423	CcSEcCtD
Desvenlafaxine—Vision blurred—Pregabalin—epilepsy syndrome	4.26e-05	0.000423	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—epilepsy syndrome	4.26e-05	0.00232	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	4.25e-05	0.00232	CbGpPWpGaD
Desvenlafaxine—Anxiety—Valproic Acid—epilepsy syndrome	4.24e-05	0.000421	CcSEcCtD
Desvenlafaxine—Tremor—Pregabalin—epilepsy syndrome	4.23e-05	0.000421	CcSEcCtD
Desvenlafaxine—Rash—Midazolam—epilepsy syndrome	4.23e-05	0.00042	CcSEcCtD
Desvenlafaxine—Dizziness—Fosphenytoin—epilepsy syndrome	4.23e-05	0.00042	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.22e-05	0.00042	CcSEcCtD
Desvenlafaxine—Dermatitis—Midazolam—epilepsy syndrome	4.22e-05	0.00042	CcSEcCtD
Desvenlafaxine—Vomiting—Levetiracetam—epilepsy syndrome	4.21e-05	0.000418	CcSEcCtD
Desvenlafaxine—Epistaxis—Topiramate—epilepsy syndrome	4.21e-05	0.000418	CcSEcCtD
Desvenlafaxine—Alopecia—Gabapentin—epilepsy syndrome	4.2e-05	0.000418	CcSEcCtD
Desvenlafaxine—Headache—Midazolam—epilepsy syndrome	4.2e-05	0.000417	CcSEcCtD
Desvenlafaxine—Diarrhoea—Diazepam—epilepsy syndrome	4.2e-05	0.000417	CcSEcCtD
Desvenlafaxine—Rash—Levetiracetam—epilepsy syndrome	4.17e-05	0.000415	CcSEcCtD
Desvenlafaxine—Dermatitis—Levetiracetam—epilepsy syndrome	4.17e-05	0.000414	CcSEcCtD
Desvenlafaxine—Asthenia—Zonisamide—epilepsy syndrome	4.17e-05	0.000414	CcSEcCtD
Desvenlafaxine—Mental disorder—Gabapentin—epilepsy syndrome	4.17e-05	0.000414	CcSEcCtD
Desvenlafaxine—Dry mouth—Valproic Acid—epilepsy syndrome	4.16e-05	0.000413	CcSEcCtD
Desvenlafaxine—Headache—Levetiracetam—epilepsy syndrome	4.15e-05	0.000412	CcSEcCtD
Desvenlafaxine—Malnutrition—Gabapentin—epilepsy syndrome	4.14e-05	0.000412	CcSEcCtD
Desvenlafaxine—Angioedema—Pregabalin—epilepsy syndrome	4.13e-05	0.00041	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Clonazepam—epilepsy syndrome	4.13e-05	0.00041	CcSEcCtD
Desvenlafaxine—Dizziness—Vigabatrin—epilepsy syndrome	4.12e-05	0.000409	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	4.11e-05	0.00224	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Phenytoin—epilepsy syndrome	4.1e-05	0.000407	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.08e-05	0.000405	CcSEcCtD
Desvenlafaxine—Nausea—Propofol—epilepsy syndrome	4.07e-05	0.000405	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	4.07e-05	0.00222	CbGpPWpGaD
Desvenlafaxine—Tension—Gabapentin—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Desvenlafaxine—Vomiting—Fosphenytoin—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Desvenlafaxine—Diarrhoea—Felbamate—epilepsy syndrome	4.06e-05	0.000404	CcSEcCtD
Desvenlafaxine—Vertigo—Pregabalin—epilepsy syndrome	4.06e-05	0.000403	CcSEcCtD
Desvenlafaxine—Dysgeusia—Gabapentin—epilepsy syndrome	4.06e-05	0.000403	CcSEcCtD
Desvenlafaxine—Dizziness—Diazepam—epilepsy syndrome	4.06e-05	0.000403	CcSEcCtD
Desvenlafaxine—Syncope—Pregabalin—epilepsy syndrome	4.05e-05	0.000402	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	4.05e-05	0.00221	CbGpPWpGaD
Desvenlafaxine—Rash—Fosphenytoin—epilepsy syndrome	4.03e-05	0.0004	CcSEcCtD
Desvenlafaxine—Dermatitis—Fosphenytoin—epilepsy syndrome	4.03e-05	0.0004	CcSEcCtD
Desvenlafaxine—Nervousness—Gabapentin—epilepsy syndrome	4.02e-05	0.0004	CcSEcCtD
Desvenlafaxine—Asthenia—Clonazepam—epilepsy syndrome	4.02e-05	0.000399	CcSEcCtD
Desvenlafaxine—Headache—Fosphenytoin—epilepsy syndrome	4e-05	0.000398	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Valproic Acid—epilepsy syndrome	4e-05	0.000397	CcSEcCtD
Desvenlafaxine—Palpitations—Pregabalin—epilepsy syndrome	3.99e-05	0.000397	CcSEcCtD
Desvenlafaxine—Asthenia—Phenytoin—epilepsy syndrome	3.99e-05	0.000397	CcSEcCtD
Desvenlafaxine—Nausea—Midazolam—epilepsy syndrome	3.98e-05	0.000396	CcSEcCtD
Desvenlafaxine—Hallucination—Topiramate—epilepsy syndrome	3.98e-05	0.000396	CcSEcCtD
Desvenlafaxine—Tachycardia—Valproic Acid—epilepsy syndrome	3.98e-05	0.000395	CcSEcCtD
Desvenlafaxine—Diarrhoea—Zonisamide—epilepsy syndrome	3.98e-05	0.000395	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.97e-05	0.000394	CcSEcCtD
Desvenlafaxine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000394	CcSEcCtD
Desvenlafaxine—Vomiting—Vigabatrin—epilepsy syndrome	3.96e-05	0.000394	CcSEcCtD
Desvenlafaxine—Skin disorder—Valproic Acid—epilepsy syndrome	3.96e-05	0.000394	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000393	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.94e-05	0.000392	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Topiramate—epilepsy syndrome	3.93e-05	0.000391	CcSEcCtD
Desvenlafaxine—Nausea—Levetiracetam—epilepsy syndrome	3.93e-05	0.000391	CcSEcCtD
Desvenlafaxine—Rash—Vigabatrin—epilepsy syndrome	3.93e-05	0.00039	CcSEcCtD
Desvenlafaxine—Dizziness—Felbamate—epilepsy syndrome	3.93e-05	0.00039	CcSEcCtD
Desvenlafaxine—Dermatitis—Vigabatrin—epilepsy syndrome	3.92e-05	0.00039	CcSEcCtD
Desvenlafaxine—Urethral disorder—Topiramate—epilepsy syndrome	3.92e-05	0.00039	CcSEcCtD
Desvenlafaxine—Convulsion—Pregabalin—epilepsy syndrome	3.91e-05	0.000389	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.91e-05	0.000389	CcSEcCtD
Desvenlafaxine—Vision blurred—Gabapentin—epilepsy syndrome	3.9e-05	0.000388	CcSEcCtD
Desvenlafaxine—Headache—Vigabatrin—epilepsy syndrome	3.9e-05	0.000388	CcSEcCtD
Desvenlafaxine—Hypertension—Pregabalin—epilepsy syndrome	3.9e-05	0.000388	CcSEcCtD
Desvenlafaxine—Vomiting—Diazepam—epilepsy syndrome	3.9e-05	0.000387	CcSEcCtD
Desvenlafaxine—Tremor—Gabapentin—epilepsy syndrome	3.88e-05	0.000386	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	3.87e-05	0.00211	CbGpPWpGaD
Desvenlafaxine—Rash—Diazepam—epilepsy syndrome	3.87e-05	0.000384	CcSEcCtD
Desvenlafaxine—Dermatitis—Diazepam—epilepsy syndrome	3.86e-05	0.000384	CcSEcCtD
Desvenlafaxine—Dizziness—Zonisamide—epilepsy syndrome	3.84e-05	0.000382	CcSEcCtD
Desvenlafaxine—Headache—Diazepam—epilepsy syndrome	3.84e-05	0.000382	CcSEcCtD
Desvenlafaxine—Anxiety—Pregabalin—epilepsy syndrome	3.83e-05	0.000381	CcSEcCtD
Desvenlafaxine—Diarrhoea—Clonazepam—epilepsy syndrome	3.83e-05	0.000381	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.82e-05	0.000379	CcSEcCtD
Desvenlafaxine—Asthenia—Carbamazepine—epilepsy syndrome	3.81e-05	0.000379	CcSEcCtD
Desvenlafaxine—Diarrhoea—Phenytoin—epilepsy syndrome	3.81e-05	0.000378	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AVP—epilepsy syndrome	3.8e-05	0.00207	CbGpPWpGaD
Desvenlafaxine—Nausea—Fosphenytoin—epilepsy syndrome	3.8e-05	0.000377	CcSEcCtD
Desvenlafaxine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.000376	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Topiramate—epilepsy syndrome	3.78e-05	0.000376	CcSEcCtD
Desvenlafaxine—Angioedema—Gabapentin—epilepsy syndrome	3.78e-05	0.000376	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.78e-05	0.000376	CcSEcCtD
Desvenlafaxine—Vomiting—Felbamate—epilepsy syndrome	3.77e-05	0.000375	CcSEcCtD
Desvenlafaxine—Dry mouth—Pregabalin—epilepsy syndrome	3.76e-05	0.000374	CcSEcCtD
Desvenlafaxine—Rash—Felbamate—epilepsy syndrome	3.74e-05	0.000372	CcSEcCtD
Desvenlafaxine—Eye disorder—Topiramate—epilepsy syndrome	3.74e-05	0.000372	CcSEcCtD
Desvenlafaxine—Dermatitis—Felbamate—epilepsy syndrome	3.74e-05	0.000372	CcSEcCtD
Desvenlafaxine—Tinnitus—Topiramate—epilepsy syndrome	3.73e-05	0.000371	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.73e-05	0.00203	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIRT1—epilepsy syndrome	3.72e-05	0.00203	CbGpPWpGaD
Desvenlafaxine—Vertigo—Gabapentin—epilepsy syndrome	3.72e-05	0.00037	CcSEcCtD
Desvenlafaxine—Headache—Felbamate—epilepsy syndrome	3.72e-05	0.00037	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Topiramate—epilepsy syndrome	3.71e-05	0.000369	CcSEcCtD
Desvenlafaxine—Syncope—Gabapentin—epilepsy syndrome	3.71e-05	0.000369	CcSEcCtD
Desvenlafaxine—Dizziness—Clonazepam—epilepsy syndrome	3.7e-05	0.000368	CcSEcCtD
Desvenlafaxine—Nausea—Vigabatrin—epilepsy syndrome	3.7e-05	0.000368	CcSEcCtD
Desvenlafaxine—Vomiting—Zonisamide—epilepsy syndrome	3.69e-05	0.000367	CcSEcCtD
Desvenlafaxine—Insomnia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000366	CcSEcCtD
Desvenlafaxine—Asthenia—Lamotrigine—epilepsy syndrome	3.68e-05	0.000366	CcSEcCtD
Desvenlafaxine—Dizziness—Phenytoin—epilepsy syndrome	3.68e-05	0.000365	CcSEcCtD
Desvenlafaxine—Rash—Zonisamide—epilepsy syndrome	3.66e-05	0.000364	CcSEcCtD
Desvenlafaxine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.66e-05	0.000364	CcSEcCtD
Desvenlafaxine—Palpitations—Gabapentin—epilepsy syndrome	3.66e-05	0.000364	CcSEcCtD
Desvenlafaxine—Dermatitis—Zonisamide—epilepsy syndrome	3.66e-05	0.000364	CcSEcCtD
Desvenlafaxine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.000364	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.65e-05	0.00199	CbGpPWpGaD
Desvenlafaxine—Nausea—Diazepam—epilepsy syndrome	3.64e-05	0.000362	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.64e-05	0.000362	CcSEcCtD
Desvenlafaxine—Headache—Zonisamide—epilepsy syndrome	3.64e-05	0.000362	CcSEcCtD
Desvenlafaxine—Diarrhoea—Carbamazepine—epilepsy syndrome	3.63e-05	0.000361	CcSEcCtD
Desvenlafaxine—Angiopathy—Topiramate—epilepsy syndrome	3.63e-05	0.000361	CcSEcCtD
Desvenlafaxine—Shock—Pregabalin—epilepsy syndrome	3.63e-05	0.00036	CcSEcCtD
Desvenlafaxine—Somnolence—Valproic Acid—epilepsy syndrome	3.62e-05	0.00036	CcSEcCtD
Desvenlafaxine—Immune system disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000359	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.61e-05	0.000359	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.61e-05	0.000358	CcSEcCtD
Desvenlafaxine—Tachycardia—Pregabalin—epilepsy syndrome	3.6e-05	0.000358	CcSEcCtD
Desvenlafaxine—Chills—Topiramate—epilepsy syndrome	3.59e-05	0.000357	CcSEcCtD
Desvenlafaxine—Convulsion—Gabapentin—epilepsy syndrome	3.59e-05	0.000357	CcSEcCtD
Desvenlafaxine—Skin disorder—Pregabalin—epilepsy syndrome	3.58e-05	0.000356	CcSEcCtD
Desvenlafaxine—Hypertension—Gabapentin—epilepsy syndrome	3.58e-05	0.000355	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.56e-05	0.000354	CcSEcCtD
Desvenlafaxine—Vomiting—Clonazepam—epilepsy syndrome	3.56e-05	0.000354	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.56e-05	0.00194	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.56e-05	0.00194	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.56e-05	0.00194	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.55e-05	0.00193	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Valproic Acid—epilepsy syndrome	3.54e-05	0.000352	CcSEcCtD
Desvenlafaxine—Alopecia—Topiramate—epilepsy syndrome	3.54e-05	0.000351	CcSEcCtD
Desvenlafaxine—Vomiting—Phenytoin—epilepsy syndrome	3.54e-05	0.000351	CcSEcCtD
Desvenlafaxine—Rash—Clonazepam—epilepsy syndrome	3.53e-05	0.000351	CcSEcCtD
Desvenlafaxine—Dermatitis—Clonazepam—epilepsy syndrome	3.53e-05	0.000351	CcSEcCtD
Desvenlafaxine—Nausea—Felbamate—epilepsy syndrome	3.53e-05	0.00035	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.52e-05	0.00192	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.52e-05	0.00035	CcSEcCtD
Desvenlafaxine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.52e-05	0.00035	CcSEcCtD
Desvenlafaxine—Fatigue—Valproic Acid—epilepsy syndrome	3.52e-05	0.000349	CcSEcCtD
Desvenlafaxine—Anxiety—Gabapentin—epilepsy syndrome	3.51e-05	0.000349	CcSEcCtD
Desvenlafaxine—Dizziness—Carbamazepine—epilepsy syndrome	3.51e-05	0.000349	CcSEcCtD
Desvenlafaxine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.51e-05	0.000349	CcSEcCtD
Desvenlafaxine—Headache—Clonazepam—epilepsy syndrome	3.51e-05	0.000349	CcSEcCtD
Desvenlafaxine—Rash—Phenytoin—epilepsy syndrome	3.51e-05	0.000348	CcSEcCtD
Desvenlafaxine—Mental disorder—Topiramate—epilepsy syndrome	3.51e-05	0.000348	CcSEcCtD
Desvenlafaxine—Dermatitis—Phenytoin—epilepsy syndrome	3.5e-05	0.000348	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.5e-05	0.00191	CbGpPWpGaD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.5e-05	0.000348	CcSEcCtD
Desvenlafaxine—Rash—Oxcarbazepine—epilepsy syndrome	3.49e-05	0.000347	CcSEcCtD
Desvenlafaxine—Constipation—Valproic Acid—epilepsy syndrome	3.49e-05	0.000346	CcSEcCtD
Desvenlafaxine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.49e-05	0.000346	CcSEcCtD
Desvenlafaxine—Headache—Phenytoin—epilepsy syndrome	3.48e-05	0.000346	CcSEcCtD
Desvenlafaxine—Malnutrition—Topiramate—epilepsy syndrome	3.48e-05	0.000346	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.48e-05	0.0019	CbGpPWpGaD
Desvenlafaxine—Headache—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000344	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.46e-05	0.00188	CbGpPWpGaD
Desvenlafaxine—Nausea—Zonisamide—epilepsy syndrome	3.45e-05	0.000343	CcSEcCtD
Desvenlafaxine—Dry mouth—Gabapentin—epilepsy syndrome	3.45e-05	0.000343	CcSEcCtD
Desvenlafaxine—Tension—Topiramate—epilepsy syndrome	3.42e-05	0.00034	CcSEcCtD
Desvenlafaxine—Dysgeusia—Topiramate—epilepsy syndrome	3.41e-05	0.000339	CcSEcCtD
Desvenlafaxine—Dizziness—Lamotrigine—epilepsy syndrome	3.39e-05	0.000337	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.39e-05	0.00185	CbGpPWpGaD
Desvenlafaxine—Nervousness—Topiramate—epilepsy syndrome	3.38e-05	0.000336	CcSEcCtD
Desvenlafaxine—Vomiting—Carbamazepine—epilepsy syndrome	3.38e-05	0.000335	CcSEcCtD
Desvenlafaxine—Rash—Carbamazepine—epilepsy syndrome	3.35e-05	0.000333	CcSEcCtD
Desvenlafaxine—Dermatitis—Carbamazepine—epilepsy syndrome	3.34e-05	0.000332	CcSEcCtD
Desvenlafaxine—Insomnia—Pregabalin—epilepsy syndrome	3.33e-05	0.000331	CcSEcCtD
Desvenlafaxine—Nausea—Clonazepam—epilepsy syndrome	3.33e-05	0.000331	CcSEcCtD
Desvenlafaxine—Headache—Carbamazepine—epilepsy syndrome	3.33e-05	0.000331	CcSEcCtD
Desvenlafaxine—Shock—Gabapentin—epilepsy syndrome	3.33e-05	0.00033	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.31e-05	0.000329	CcSEcCtD
Desvenlafaxine—Paraesthesia—Pregabalin—epilepsy syndrome	3.31e-05	0.000329	CcSEcCtD
Desvenlafaxine—Nausea—Phenytoin—epilepsy syndrome	3.3e-05	0.000328	CcSEcCtD
Desvenlafaxine—Tachycardia—Gabapentin—epilepsy syndrome	3.3e-05	0.000328	CcSEcCtD
Desvenlafaxine—Nausea—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000327	CcSEcCtD
Desvenlafaxine—Vision blurred—Topiramate—epilepsy syndrome	3.28e-05	0.000326	CcSEcCtD
Desvenlafaxine—Skin disorder—Gabapentin—epilepsy syndrome	3.28e-05	0.000326	CcSEcCtD
Desvenlafaxine—Somnolence—Pregabalin—epilepsy syndrome	3.28e-05	0.000326	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.27e-05	0.000325	CcSEcCtD
Desvenlafaxine—Tremor—Topiramate—epilepsy syndrome	3.26e-05	0.000324	CcSEcCtD
Desvenlafaxine—Vomiting—Lamotrigine—epilepsy syndrome	3.26e-05	0.000324	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.26e-05	0.00178	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.25e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.25e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.25e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.25e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—Rash—Lamotrigine—epilepsy syndrome	3.24e-05	0.000321	CcSEcCtD
Desvenlafaxine—Dermatitis—Lamotrigine—epilepsy syndrome	3.23e-05	0.000321	CcSEcCtD
Desvenlafaxine—Headache—Lamotrigine—epilepsy syndrome	3.21e-05	0.000319	CcSEcCtD
Desvenlafaxine—Decreased appetite—Pregabalin—epilepsy syndrome	3.2e-05	0.000318	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.18e-05	0.000316	CcSEcCtD
Desvenlafaxine—Fatigue—Pregabalin—epilepsy syndrome	3.18e-05	0.000316	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.16e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—Nausea—Carbamazepine—epilepsy syndrome	3.15e-05	0.000313	CcSEcCtD
Desvenlafaxine—Constipation—Pregabalin—epilepsy syndrome	3.15e-05	0.000313	CcSEcCtD
Desvenlafaxine—Vertigo—Topiramate—epilepsy syndrome	3.13e-05	0.000311	CcSEcCtD
Desvenlafaxine—Syncope—Topiramate—epilepsy syndrome	3.12e-05	0.000311	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.12e-05	0.0017	CbGpPWpGaD
Desvenlafaxine—Palpitations—Topiramate—epilepsy syndrome	3.08e-05	0.000306	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Topiramate—epilepsy syndrome	3.06e-05	0.000304	CcSEcCtD
Desvenlafaxine—Insomnia—Gabapentin—epilepsy syndrome	3.06e-05	0.000304	CcSEcCtD
Desvenlafaxine—Nausea—Lamotrigine—epilepsy syndrome	3.05e-05	0.000303	CcSEcCtD
Desvenlafaxine—Paraesthesia—Gabapentin—epilepsy syndrome	3.04e-05	0.000302	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.02e-05	0.00165	CbGpPWpGaD
Desvenlafaxine—Convulsion—Topiramate—epilepsy syndrome	3.02e-05	0.0003	CcSEcCtD
Desvenlafaxine—Hypertension—Topiramate—epilepsy syndrome	3.01e-05	0.000299	CcSEcCtD
Desvenlafaxine—Somnolence—Gabapentin—epilepsy syndrome	3e-05	0.000299	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3e-05	0.000299	CcSEcCtD
Desvenlafaxine—Anxiety—Topiramate—epilepsy syndrome	2.96e-05	0.000294	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.95e-05	0.000293	CcSEcCtD
Desvenlafaxine—Decreased appetite—Gabapentin—epilepsy syndrome	2.94e-05	0.000292	CcSEcCtD
Desvenlafaxine—Asthenia—Valproic Acid—epilepsy syndrome	2.93e-05	0.000291	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.92e-05	0.00029	CcSEcCtD
Desvenlafaxine—Fatigue—Gabapentin—epilepsy syndrome	2.91e-05	0.00029	CcSEcCtD
Desvenlafaxine—Dry mouth—Topiramate—epilepsy syndrome	2.9e-05	0.000288	CcSEcCtD
Desvenlafaxine—Constipation—Gabapentin—epilepsy syndrome	2.89e-05	0.000287	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.88e-05	0.00157	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.87e-05	0.00156	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.86e-05	0.00156	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.84e-05	0.00155	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.84e-05	0.00155	CbGpPWpGaD
Desvenlafaxine—Shock—Topiramate—epilepsy syndrome	2.8e-05	0.000278	CcSEcCtD
Desvenlafaxine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.79e-05	0.000277	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000277	CcSEcCtD
Desvenlafaxine—Tachycardia—Topiramate—epilepsy syndrome	2.78e-05	0.000276	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.77e-05	0.00151	CbGpPWpGaD
Desvenlafaxine—Skin disorder—Topiramate—epilepsy syndrome	2.76e-05	0.000274	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.75e-05	0.000273	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—epilepsy syndrome	2.74e-05	0.00149	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.72e-05	0.00027	CcSEcCtD
Desvenlafaxine—Dizziness—Valproic Acid—epilepsy syndrome	2.7e-05	0.000268	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.66e-05	0.00145	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.66e-05	0.00145	CbGpPWpGaD
Desvenlafaxine—Asthenia—Pregabalin—epilepsy syndrome	2.64e-05	0.000263	CcSEcCtD
Desvenlafaxine—Vomiting—Valproic Acid—epilepsy syndrome	2.59e-05	0.000258	CcSEcCtD
Desvenlafaxine—Insomnia—Topiramate—epilepsy syndrome	2.57e-05	0.000256	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.57e-05	0.0014	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.57e-05	0.0014	CbGpPWpGaD
Desvenlafaxine—Rash—Valproic Acid—epilepsy syndrome	2.57e-05	0.000255	CcSEcCtD
Desvenlafaxine—Dermatitis—Valproic Acid—epilepsy syndrome	2.57e-05	0.000255	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.56e-05	0.0014	CbGpPWpGaD
Desvenlafaxine—Headache—Valproic Acid—epilepsy syndrome	2.55e-05	0.000254	CcSEcCtD
Desvenlafaxine—Paraesthesia—Topiramate—epilepsy syndrome	2.55e-05	0.000254	CcSEcCtD
Desvenlafaxine—Somnolence—Topiramate—epilepsy syndrome	2.53e-05	0.000251	CcSEcCtD
Desvenlafaxine—Diarrhoea—Pregabalin—epilepsy syndrome	2.52e-05	0.000251	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.49e-05	0.000247	CcSEcCtD
Desvenlafaxine—Decreased appetite—Topiramate—epilepsy syndrome	2.47e-05	0.000246	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.46e-05	0.00134	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.46e-05	0.000244	CcSEcCtD
Desvenlafaxine—Fatigue—Topiramate—epilepsy syndrome	2.45e-05	0.000244	CcSEcCtD
Desvenlafaxine—Dizziness—Pregabalin—epilepsy syndrome	2.44e-05	0.000242	CcSEcCtD
Desvenlafaxine—Constipation—Topiramate—epilepsy syndrome	2.43e-05	0.000242	CcSEcCtD
Desvenlafaxine—Asthenia—Gabapentin—epilepsy syndrome	2.43e-05	0.000241	CcSEcCtD
Desvenlafaxine—Nausea—Valproic Acid—epilepsy syndrome	2.42e-05	0.000241	CcSEcCtD
Desvenlafaxine—Vomiting—Pregabalin—epilepsy syndrome	2.34e-05	0.000233	CcSEcCtD
Desvenlafaxine—Rash—Pregabalin—epilepsy syndrome	2.32e-05	0.000231	CcSEcCtD
Desvenlafaxine—Dermatitis—Pregabalin—epilepsy syndrome	2.32e-05	0.000231	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gabapentin—epilepsy syndrome	2.31e-05	0.00023	CcSEcCtD
Desvenlafaxine—Headache—Pregabalin—epilepsy syndrome	2.31e-05	0.000229	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.29e-05	0.00125	CbGpPWpGaD
Desvenlafaxine—Dizziness—Gabapentin—epilepsy syndrome	2.24e-05	0.000222	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.22e-05	0.00121	CbGpPWpGaD
Desvenlafaxine—Nausea—Pregabalin—epilepsy syndrome	2.19e-05	0.000218	CcSEcCtD
Desvenlafaxine—Vomiting—Gabapentin—epilepsy syndrome	2.15e-05	0.000214	CcSEcCtD
Desvenlafaxine—Rash—Gabapentin—epilepsy syndrome	2.13e-05	0.000212	CcSEcCtD
Desvenlafaxine—Dermatitis—Gabapentin—epilepsy syndrome	2.13e-05	0.000212	CcSEcCtD
Desvenlafaxine—Headache—Gabapentin—epilepsy syndrome	2.12e-05	0.00021	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.1e-05	0.00114	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Topiramate—epilepsy syndrome	2.1e-05	0.000208	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.04e-05	0.00111	CbGpPWpGaD
Desvenlafaxine—Asthenia—Topiramate—epilepsy syndrome	2.04e-05	0.000203	CcSEcCtD
Desvenlafaxine—Nausea—Gabapentin—epilepsy syndrome	2.01e-05	0.0002	CcSEcCtD
Desvenlafaxine—Diarrhoea—Topiramate—epilepsy syndrome	1.95e-05	0.000193	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.94e-05	0.00106	CbGpPWpGaD
Desvenlafaxine—Dizziness—Topiramate—epilepsy syndrome	1.88e-05	0.000187	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUN—epilepsy syndrome	1.81e-05	0.000989	CbGpPWpGaD
Desvenlafaxine—Vomiting—Topiramate—epilepsy syndrome	1.81e-05	0.00018	CcSEcCtD
Desvenlafaxine—Rash—Topiramate—epilepsy syndrome	1.79e-05	0.000178	CcSEcCtD
Desvenlafaxine—Dermatitis—Topiramate—epilepsy syndrome	1.79e-05	0.000178	CcSEcCtD
Desvenlafaxine—Headache—Topiramate—epilepsy syndrome	1.78e-05	0.000177	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.74e-05	0.000947	CbGpPWpGaD
Desvenlafaxine—Nausea—Topiramate—epilepsy syndrome	1.69e-05	0.000168	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.66e-05	0.000907	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.66e-05	0.000903	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.61e-05	0.000878	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.55e-05	0.000844	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.52e-05	0.000827	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.51e-05	0.000822	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.5e-05	0.000816	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.49e-05	0.000811	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.36e-05	0.000743	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.36e-05	0.000742	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.35e-05	0.000736	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.34e-05	0.000732	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.31e-05	0.000713	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.26e-05	0.000684	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.04e-05	0.000566	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.18e-06	0.000446	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.87e-06	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.2e-06	0.000392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.2e-06	0.000392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.2e-06	0.000392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.2e-06	0.000392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.69e-06	0.000365	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.69e-06	0.000365	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.67e-06	0.000363	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.29e-06	0.000343	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.96e-06	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.96e-06	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.96e-06	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.96e-06	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.96e-06	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.45e-06	0.000297	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.45e-06	0.000297	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.45e-06	0.000297	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.25e-06	0.000286	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.07e-06	0.000276	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.07e-06	0.000276	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.77e-06	0.00026	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.64e-06	0.000253	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.52e-06	0.000246	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.52e-06	0.000246	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.31e-06	0.000235	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.31e-06	0.000235	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.22e-06	0.00023	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.13e-06	0.000225	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.05e-06	0.000221	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.98e-06	0.000217	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.72e-06	0.000203	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.61e-06	0.000197	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.27e-06	0.000178	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.27e-06	0.000178	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.66e-06	0.000145	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.6e-06	0.000141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.58e-06	0.000141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.33e-06	0.000127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.22e-06	0.000121	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.21e-06	0.00012	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.11e-06	0.000115	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.08e-06	0.000113	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.07e-06	0.000113	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.73e-06	9.44e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.71e-06	9.31e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.66e-06	9.06e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.55e-06	8.42e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.35e-06	7.38e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.33e-06	7.24e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.14e-06	6.22e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.04e-06	5.67e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.1e-07	4.96e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.57e-07	2.49e-05	CbGpPWpGaD
